Literature DB >> 7262178

Prolonged Q-T interval and severe tachyarrhythmias, common features of sotalol intoxication.

P J Neuvonen, E Elonen, T Vuorenmaa, M Laakso.   

Abstract

The findings in six patients admitted to hospital 0.5-4.5 h after the ingestion of an overdose of 2.4-8 g sotalol are described. In addition to bradycardia and hypotension, all patients had a considerably prolonged corrected Q-T interval, up to 172 +/- 8% of normal. Severe ventricular tachyarrhythmias occurred in five of the six patients, the risk was greatest up to 20 h after the ingestion of sotalol. The long Q-T interval returned to normal over 3 to 4 days, which is consistent with the long half-life of sotalol. In addition to its beta-blocking action, sotalol has marked electrophysiological properties of a Class III antiarrhythmic drugs, which are likely to be able to account for its observed effects. Special attention should be paid to the risk of severe ventricular arrhythmias in sotalol intoxications.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7262178     DOI: 10.1007/BF00607142

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  18 in total

Review 1.  [Re-entry mechanism of ventricular tachycardias in inhomogenic repolarization. With special reference to Jervell-Lange-Nielsen syndrome and similar states and their therapy].

Authors:  K Theisen; H Jahrmärker
Journal:  Dtsch Med Wochenschr       Date:  1975-05-16       Impact factor: 0.628

Review 2.  Electrophysiology and pharmacology of cardiac arrhythmias. IX. Cardiac electrophysiologic effects of beta adrenergic receptro stimulation and blockade. Part C.

Authors:  A L Wit; B F Hoffman; M R Rosen
Journal:  Am Heart J       Date:  1975-12       Impact factor: 4.749

3.  Observations on the efficacy and pharmacokinetics of sotalol after oral administration.

Authors:  H C Brown; S G Carruthers; J G Kelly; D G McDevitt; R G Shanks
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

4.  Antihypertensive effects of practolol and sotalol.

Authors:  H Sundquist; M Anttila; M Arstila
Journal:  Clin Pharmacol Ther       Date:  1974-09       Impact factor: 6.875

5.  Electrophysiologial and beta-receptor blocking effects of MJ 1999 on dog and rabbit cardiac tissue.

Authors:  H C Strauss; J T Bigger; B F Hoffman
Journal:  Circ Res       Date:  1970-06       Impact factor: 17.367

6.  Sotalol: a new, safe beta adrenergic receptor blocking agent.

Authors:  W S Frankl; L A Soloff
Journal:  Am J Cardiol       Date:  1968-08       Impact factor: 2.778

7.  Beta-blocker poisoning.

Authors: 
Journal:  Lancet       Date:  1980-04-12       Impact factor: 79.321

8.  Fatal sotalol poisoning.

Authors:  M Montagna; A Groppi
Journal:  Arch Toxicol       Date:  1980-01       Impact factor: 5.153

9.  Sotalol intoxication, two patients with concentration-effect relationships.

Authors:  P J Neuvonen; E Elonen; L Tarssanen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1979-07

10.  Amiodarone-induced ventricular fibrillation.

Authors:  J M McComb; K R Logan; M M Khan; J S Geddes; A A Adgey
Journal:  Eur J Cardiol       Date:  1980
View more
  17 in total

1.  Field and action potential recordings in heart slices: correlation with established in vitro and in vivo models.

Authors:  Herbert M Himmel; Alexandra Bussek; Michael Hoffmann; Rolf Beckmann; Horst Lohmann; Matthias Schmidt; Erich Wettwer
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 2.  A prolonged QTc interval. Is it an important effect of antiarrhythmic drugs?

Authors:  F A Fish; D M Roden
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Nov-Dec

Review 3.  Antiarrhythmic drug classifications. A critical appraisal of their history, present status, and clinical relevance.

Authors:  S Nattel
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

4.  EJCP and clinical toxicology: the first 40 years.

Authors:  D N Bateman
Journal:  Eur J Clin Pharmacol       Date:  2007-11-16       Impact factor: 2.953

5.  The role of concentration--effect relationships in the QTc interval prolongation: case sotalol.

Authors:  Pertti J Neuvonen; Erkki Elonen
Journal:  Br J Clin Pharmacol       Date:  2015-06       Impact factor: 4.335

Review 6.  Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

Authors:  B N Singh; P Deedwania; K Nademanee; A Ward; E M Sorkin
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

7.  The combined electrophysiological effects of lignocaine and sotalol in canine isolated cardiac Purkinje fibres are rate-dependent.

Authors:  D A Lathrop; A Varró
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

Review 8.  Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.

Authors:  A Fitton; E M Sorkin
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

9.  Sotalol, hypokalaemia, syncope, and torsade de pointes.

Authors:  J K McKibbin; W A Pocock; J B Barlow; R N Millar; I W Obel
Journal:  Br Heart J       Date:  1984-02

Review 10.  Class III antiarrhythmics in overdose. Presenting features and management principles.

Authors:  E W Leatham; D W Holt; W J McKenna
Journal:  Drug Saf       Date:  1993-12       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.